FHI vs LAZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

FHI

58.7
AI Score
VS
LAZ Wins

LAZ

65.1
AI Score

Investment Advisor Scores

FHI

Oct 02, 2026
59score
Recommendation
HOLD

LAZ

Oct 02, 2026
65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI LAZ Winner
Forward P/E 9.9206 10.395 FHI
PEG Ratio 1.3978 1.0002 LAZ
Revenue Growth 18.3% 0.1% FHI
Earnings Growth 19.3% -94.2% FHI
Tradestie Score 58.7/100 65.1/100 LAZ
Profit Margin 21.3% 7.1% FHI
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FHI 1M: -7.7% · 3M: -3.2% LAZ 1M: -16.0% · 3M: -16.7%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 33.1 · Price: $56.07

LAZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.7%), weak momentum, RSI 35

RSI (14): 34.8 · Price: $36.07

Fundamentals Snapshot

Metric FHI LAZ
Market Cap — —
Forward P/E 9.5 9.4
Trailing P/E 10.4 17.9
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.7% 0.9%
Operating Margin 0.3% 0.0%
EPS 5.38 2.04
Dividend Yield 0.02% 0.06%

Frequently Asked Questions

Based on our detailed analysis, LAZ is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.